Acupuncture Clinical Analytical Instruments for Easing Fatigue

Name: Acupuncture Clinical Analytical Instruments for Easing Fatigue
Brand: Shinylink (Shanghai) Industrial Inc.
SKU: 731523642

Shanghai, ChinaShinylink (Shanghai) Industrial Inc.

US$24.00-32.00

10 unit

Sample price:US$60.00/unit.Request sample

Product profile

Customization

Available

Shape

Oral Liquid

Function

Physical Therapy, Massage

Model NO.

GB-68A

Application

Chinese Medicine Treatment

Usage Mode

For oral administration

Suitable for

Elderly, Children, Adult

State

Liquid

Name

Acupuncture Stimulator

Place of Origin

Jiangsu, China (Mainland)

Sample Order

Offered

Certificate

Therapy

Electronic Acupuncture Therapy

Delivery Time

Shipped in 25 Days After Payment

Brand Name

GB-68A

Technique

Chinese Medicine Treatment

Sample

Available

Transport Package

Box/Carton

Specification

10 units/carton

Trademark

Gaoba

Origin

China

HS Code

9019101000

Production Capacity

3000 Unit/Units Per Month

Company profile

Shinylink (Shanghai) Industrial Inc.

Shanghai, China

CertifiedBusiness Type: Trading CompanyExport Year: 2013-05-01 CertifiedNearest Port: Shanghai port, Ningbo port, Qingdao port, Tianjing portAverage Response Time: ≤7.18h CertifiedTerms of Payment: T/T, PayPal, Western Union CertifiedInternational Commercial Terms(Incoterms): FOB, CIF, CFR

AI-Powered supplier vetting

SummaryShinylink (Shanghai) Industrial Inc. is a China-based trading company established in 2013, with its head office in Shanghai and reported factory operations in Suzhou. It focuses on acupuncture, cupping, moxa, guasha, jade, and related health-care products. The supplier reports ISO 13485, CE, and FDA 510(k) certifications, OEM services, short delivery times, broad export coverage, and 90% export sales. Production-related information includes 50 million acupuncture needles, more than 10 production lines, and 11–20 quality-control staff, although the relationship between these facilities and the trading company is not fully clarified. A named manufacturing partner is cited, and one trade record is shown, but customer-case evidence remains limited. Financial information is insufficient for a full credibility assessment.

Supplier typeThe supplier is explicitly identified as a trading company and limited company, legally named Shinylink (Shanghai) Industrial Inc., with its head office in Shanghai, China. This indicates an intermediary or trading-oriented business structure rather than clearly documented direct manufacturing ownership.

CertificationsThe company states that its products have ISO 13485 certificates, CE certification, and FDA-approved 510(k) certification. These are explicit certification claims, although the provided information does not include certificate numbers, validity dates, or verification documents.

After-Sales capabilityThe supplier describes its customer-service team as highly praised, reports loyal partners, and claims efficient service. It also states delivery times within 15 working days in both off-peak and peak seasons, supporting responsiveness, but no specific warranty, complaint-handling, or after-sales procedure is provided.

Production capacityReported production information includes 50 million acupuncture needles, more than 10 production lines, and 11–20 quality-control staff. A Suzhou factory location is provided, but the supplier is classified as a trading company and the ownership or operational control of the stated factory is not clearly established.

Customization capabilityThe supplier explicitly offers OEM facilities and states that it can engrave customer logos on glass cupping jars. These statements provide direct evidence of product customization for at least certain product categories.

Client casesThe supplier names Wujiang Shenlong Healthcare Products Co., Ltd. as a manufacturing partner supporting international sales and cites loyal partners. A separate trade record identifies ABC TRADE & INVESTMENTS PVT LTD as a buyer, but only one transaction is shown, so the breadth and depth of customer-case evidence are limited.